Log in to search using one of your social media accounts:

 

California's uninsured rate hits lowest level ever
The number of people with health insurance hit a record high in the California this year, according to data from the Centers for Disease Control and Prevention released this week. California’s uninsured rate dropped from 7.2 percent in 2016 to 6.8 percent from January to June — outpacing the federal rate for states supported by the federal insurance marketplace, Healthcare.gov. “It was nice to see that California also had good company among states dramatically reduci ng their uninsured population,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 22, 2017 Category: Biotechnology Authors: Antoinette Siu Source Type: news

Learning to spot a structural flaw early
If flaws in infrastructure - a ship or a bridge for example - are spotted early, the damage can be repaired before anyone gets hurt, and before the costs mount. It's a nice theory, but there are currently many uncertainties in ensuring structural safety, as well as a lack of specialists. An EU-funded project is addressing both problems. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 22, 2017 Category: Research Source Type: news

The spray's the thing: how actors use perfumes to get into character
Playing Thatcher? Dab on Bluebell. Got a part in Hairspray? Reach for the Madame Rochas. We lift the lid on how actors use smells – from the finest fragrances to cheap tinned mackerel – to nail a roleBefore I go on stage, says Michael Ball, I ask myself a question: “Do I smell nice for all the ladies and gentlemen?” The actor chooses a signature scent for each of his roles, from bay rum for the vengeful barberSweeney Todd to his mum ’s favourite Madame Rochas forHairspray’s Edna Turnblad.Ball ’s not alone in deploying scent to to get beneath a character’s skin. Anne-Marie Duf...
Source: Guardian Unlimited Science - November 20, 2017 Category: Science Authors: David Jays Tags: Theatre Stage Culture Fragrance Fashion Life and style Dance Ballet Lauren Cuthbertson Anne-Marie Duff Nikki Amuka-Bird Health, mind and body Books Psychology Science Oscar Wilde Source Type: news

Breast cancer patients to have routine access to two life extending drugs after new deal say NICE
NICE has recommended palbociclib and ribociclib for routine funding after the companies lowered the prices and gave more evidence for their effectiveness. (Source: NHS Networks)
Source: NHS Networks - November 20, 2017 Category: UK Health Source Type: news

Is There Hope for an Endologix Comeback?
A year ago, Endologix CEO John McDermott walked into the VEITHsymposium at the New York Hilton-Midtown, saw the look on the face of his head of regulatory and clinical affairs as he approached the Endologix booth, and knew something was wrong. Sure enough, FDA had just asked Endologix to provide two-year patient follow-up data from its EVAS-FORWARD study of the Nellix endovascular aneurysm sealing (EVAS) system. "So that night we worked through the night to get out our press release first thing the next morning to inform the world that there was going to be pushback in the timeline and the clinical requirements,&...
Source: MDDI - November 19, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Source Type: news

NICE gives green light to new 'breakthrough' breast cancer drugs
Discount price deals for two similar new breast cancer drugs have seen them approved for routine NHS use, under draft guidance from the National Institute for Health and Care Excellence. (Source: Nursing Times)
Source: Nursing Times - November 16, 2017 Category: Nursing Source Type: news

Thousands to benefit as 'breakthrough' breast cancer drugs approved for NHS use
Annually, 8,000 women in England with previously untreatable advanced breast cancer will have access to drugs shown to slow disease ’s progressionThousands of women with previously untreatable breast cancer will have access to two “breakthrough” drugs that have been approved for NHS use.The drugs, called palbociclib and ribociclib, have been shown to slow the progression of advanced cancer by at least 10 months and can delay the need for chemotherapy, giving women the chance to live a normal life for longer. In new draft guidance, the National Institute for Health and Care Excellence (Nice) has approved t...
Source: Guardian Unlimited Science - November 16, 2017 Category: Science Authors: Hannah Devlin Tags: Breast cancer Health Society Science The National Institute for Health and Care Excellence (Nice) NHS Drugs Source Type: news

NICE approves breakthrough breast cancer drugs
New class of cancer treatment drugs approved for NHS Related items fromOnMedica The genetics of breast cancer Ovarian cancer drug may help stall breast cancer Experts recommend anastrozole for postmenopausal women with family history of breast cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 16, 2017 Category: UK Health Source Type: news

Commissioning children's palliative care in England: 2017 edition
This report highlights that only a third of CCGs in England are implementing NICE clinical guidance to the prioritisation of palliative care for babies, children and young people. (Source: NHS Networks)
Source: NHS Networks - November 16, 2017 Category: UK Health Source Type: news

Am I a narcissist? You asked Google – here’s the answer | Anouchka Grose
Every day millions of internet users ask Google life ’s most difficult questions, big and small. Our writers answer some of the commonest queriesInevitably, yes. The question is, how deep is your love?Narcissism is seen by some as a matter of layering. ForFreud, there is primary and secondary narcissism – primary narcissism meaning the drive for self-preservation, and secondary narcissism meaning seeing yourself as if from the outside and thinking, you are great. You’re pretty much born with the first one (although it can get eroded), and then the second one comes along later. If you’re a bas ically...
Source: Guardian Unlimited Science - November 15, 2017 Category: Science Authors: Anouchka Grose Tags: Psychology Life and style Science Source Type: news

NICE seeks members for adoption and impact reference panel
NICE is looking for finance and commissioning professionals, pharmacists, providers and managers of health and care services to join its adoption and impact reference panel. (Source: NHS Networks)
Source: NHS Networks - November 14, 2017 Category: UK Health Source Type: news

Implementing the National Institute for Health and Clinical Excellence Head Injury 2014 Guidelines in a major children's hospital emergency department - Ramjeeawon N, Lecky F, Burke DP, Ramlakhan S.
OBJECTIVES AND BACKGROUND: Head injury is a common paediatric emergency department presentation. The National Institute for Health and Clinical Excellence updated its guidance in January 2014 regarding imaging required for adults and children following a h... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Two thirds of eye units restricting access to cataract surgery
Commissioners are ignoring NICE guidance, says Royal College of Ophthalmologists Related items fromOnMedica Eye problems Hopes for early warning glaucoma detector STPs can help CCGs deliver eye care at scale Ongoing concerns that cataract surgery being cut to save cash (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 10, 2017 Category: UK Health Source Type: news

NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
First multiple sclerosis (MS) therapy to achieve positive NICE recommendation in the shortest possible timeframe Mavenclad has shown sustained clinical efficacy up to four years with a maximum of 20 days of oral treatment over two years DARMSTADT, Ge... Biopharmaceuticals, Neurology, Regulatory Merck, Cladribine, MAVENCLAD, multiple sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2017 Category: Pharmaceuticals Source Type: news

People at a low risk of developing glaucoma can avoid unnecessary referral
NICE ’s updated guideline on glaucoma will mean fewer people need to be referred for further specialist investigation and possible treatment. (Source: NHS Networks)
Source: NHS Networks - November 9, 2017 Category: UK Health Source Type: news

Help older people with learning disabilities plan for the future, says NICE
NICE recommends health and social care professionals help older people with learning disabilities live healthy and fulfilling lives as they age, including planning for life-changing events. (Source: NHS Networks)
Source: NHS Networks - November 8, 2017 Category: UK Health Source Type: news

Apollo 12 Astronaut Richard Gordon Dies at 88
(WASHINGTON) — Former Apollo 12 astronaut Richard Gordon, one of a dozen men who flew around the moon but didn’t land there, has died, NASA said. He was 88. Richard “Dick” F. Gordon Jr. was a test pilot chosen in NASA’s third group of astronauts in 1963. He flew on Gemini 11 in 1966, walking in space twice. During Apollo 12 in November 1969, Gordon circled the moon in the command module Yankee Clipper while Alan Bean and Charles Conrad landed and walked on the lunar surface. Gordon died Monday at his home in California, according to the Astronaut Scholarship Foundation. “Dick will be fo...
Source: TIME: Top Science and Health Stories - November 7, 2017 Category: Science Authors: Seth Borenstein / AP Tags: Uncategorized onetime remembrance space Source Type: news

Parent-to-parent: Tips for Home Parenteral Nutrition families
Four-year-old Thomas Onorato is a young zoologist at heart. Often seen with binoculars in hand, the adventurous preschooler is particularly drawn to bird watching. He enjoys talking about his feathery friends and studying their beauty and habitat. Thomas’ love of animals runs so deep that he says he wants to be a veterinarian when he grows up. “Thomas is obsessed with animals. It’s his love,” says his mother, Melissa. Beyond his quest to care for animals, Thomas has two other important missions — to manage the rare condition, microvillus inclusion disease (MVID) and receive the ...
Source: Thrive, Children's Hospital Boston - November 7, 2017 Category: Pediatrics Authors: Maureen McCarthy Tags: Our Patients’ Stories Parenting Dr. Bram Raphael home parenteral nutrition Microvillus inclusion disease Source Type: news

Delayed NICE guidance on asthma diagnosis may cause problems for GPs
NICE guidance on diagnosing asthma could be published this week after nearly five years in development, but looks set to clash with existing advice - potentially leaving GPs unclear over best practice. (Source: GP Online News)
Source: GP Online News - November 6, 2017 Category: Primary Care Tags: 15.8 Respiratory Problems Source Type: news

Prescriptions of statins are missing the mark: New study finds they are being given to people who don't need them, and not being given to people who do need them
(Natural News) Statins are being prescribed to and misused by patients who are otherwise at low risk of developing heart disease, according to a study carried out by the National Institute for Health and Care Excellence (NICE) in the United Kingdom. This indicates that the drugs are being given to people who do not need them, and not... (Source: NaturalNews.com)
Source: NaturalNews.com - November 6, 2017 Category: Consumer Health News Source Type: news

NICE urges hunt for patients with high cholesterol condition
GPs and nurses have been told they must do more to seek out people at risk of an inherited condition that causes exceptionally high cholesterol. (Source: Nursing Times)
Source: Nursing Times - November 3, 2017 Category: Nursing Source Type: news

Scheme published to fast-track access to crucial medicines
Big Pharma boss appointed to lead the new pathway Related items fromOnMedica Pharmaceutical industry regulation undermines NICE drugs appraisal work NICE fast-tracks approval of new skin cancer treatment UK spends 20% less on cancer treatment than rest of EU Pharma trade body rejects appeal for judicial review after High Court ruling The medicine price debate (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 3, 2017 Category: UK Health Source Type: news

Updated NICE guidance on inherited risk of high cholesterol
Medical records should be checked to identify people who may be at risk of common inherited cholesterol disorder familial hypercholesterolaemia (FH), NICE says. (Source: NHS Networks)
Source: NHS Networks - November 3, 2017 Category: UK Health Source Type: news

UK's NICE Gives Roche Drug Green Light for Bladder Cancer UK's NICE Gives Roche Drug Green Light for Bladder Cancer
Britain's healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche's immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 2, 2017 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

7 Ways Family Members Re-victimize Sexual Abuse Survivors
Twenty years ago when I first disclosed to my family that I had been sexually abused by my brother as a child, I never would have guessed it would mark the beginning of a long, confusing struggle that would leave me feeling misunderstood, dismissed and even punished for choosing to address my abuse and its effects. The response from my family did not start out this way. Initially, my mother said the words I needed to hear: she believed me, she was pained for both her children, and she was sorry. My brother acknowledged the truth and even apologized. But as I continued to heal and explore the abuse further, my family membe...
Source: Psych Central - November 2, 2017 Category: Psychiatry Authors: MIranda Pacchiana, MSW Tags: Abuse Dreams Family Personal Stories PTSD Self-Esteem Sleep Trauma Child Sex Abuse Denial invalidation Molestation revictimization Sexual Abuse Trauma History Traumatic Childhood Source Type: news

GPs should scour records for familial hypercholesterolaemia risk, says NICE
GPs should systematically examine their records to identify patients who may have familial hypercholesterolaemia (FH), according to updated NICE guidance. (Source: GP Online News)
Source: GP Online News - November 2, 2017 Category: Primary Care Tags: 15.1 Cardiovascular Problems Source Type: news

Inherited high cholesterol should be identified and treated early
NICE updates guidance on familial hypercholesterolaemia Related items fromOnMedica Test all toddlers for inherited high cholesterol, study suggests Cholesterol – monitoring lipid levels and assessing cardiovascular risk Key evidence supporting the lowering of cholesterol Modifying cardiovascular risks and lipid modification Statins benefit children with familial hypercholesterolaemia (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 2, 2017 Category: UK Health Source Type: news

Policy and regulation stand in the way of NHS use of unlicensed eye injection drug with potential to save millions of pounds
Eye injection drugs recommended by NICE cost the NHS up to £ 447 million annually, but could be replaced by an unlicensed drug, bevacizumab, costing as much as ten times less. Use of the two licensed drugs, ranibizumab and aflibercept, has increased three-fold over the last five years, with some parts of England treating five times as many patients as others. (Source: University of Bristol news)
Source: University of Bristol news - November 1, 2017 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

UK's NICE gives Roche drug green light for bladder cancer
LONDON (Reuters) - Britain's healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche's immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer. (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

NICE's first guideline on cystic fibrosis endorses telemedicine
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2017 Category: Drugs & Pharmacology Source Type: news

NICE draft guidance approves gene therapy for rare syndrome
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2017 Category: Drugs & Pharmacology Source Type: news

Take a patient-centred approach to treating cataracts, says NICE
The decision to have cataract surgery should be based on whether the patient thinks surgery is right for them, says NICE in new guidance. (Source: NHS Networks)
Source: NHS Networks - October 31, 2017 Category: UK Health Source Type: news

Make the Diagnosis: Woodland Walk Goes Wrong
(MedPage Today) -- A 28-year-old woman visiting friends in Connecticut went to urgent care with multiple skin lesions on her legs after taking a stroll in the woods the previous morning. She said that first her skin felt like it was burning, then painful erythematous lesions appeared, and then vesicles had formed. They had walked through a field of pretty wildflowers to take photos on the nice sunny day, but otherwise had stayed on the trail. The patient was certain she hadn't come in contact with any poison ivy because she had been on the lookout for it. Can you diagnose the patient? (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 30, 2017 Category: Dermatology Source Type: news

Antibiotics 'not needed' for most sinus infections, says NICE
The majority of people with sinus infections will get better without antibiotics and so do not need to be prescribed them according to new official guidance from the National Institute for Health and Care Excellence. (Source: Nursing Times)
Source: Nursing Times - October 27, 2017 Category: Nursing Source Type: news

PHE warns to not prescribe antibiotics for sinusitis
Nice has announced new guidance that stresses most sinus infections will resolve without need for antibiotics, which are becoming ineffective. Public Health England were also on board. (Source: the Mail online | Health)
Source: the Mail online | Health - October 27, 2017 Category: Consumer Health News Source Type: news

GPs should not prescribe antibiotics for sinusitis, NICE says
Antibiotics should not be used to treat the majority of sinus infections, NICE has said. (Source: GP Online News)
Source: GP Online News - October 27, 2017 Category: Primary Care Tags: Clinical News Source Type: news

Massive fall in animal antibiotic use
Ministers says reduction will help combat rising rates of antibiotic resistance Related items fromOnMedica No evidence to back mantra that patients need to complete antibiotic course Children with asthma prescribed ‘unnecessary antibiotics’ Antibiotics for women in early labour to combat Group B Strep Antibiotics not recommended for acute otitis, says NICE Dipstick test children ’s urine before prescribing antibiotics (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 27, 2017 Category: UK Health Source Type: news

People with cystic fibrosis could be monitored through phone or video messaging says NICE
Patients with cystic fibrosis could avoid having to travel to specialist clinics if health professionals could monitor them using phone or video messaging. (Source: NHS Networks)
Source: NHS Networks - October 26, 2017 Category: UK Health Source Type: news

NICE issues first briefing on ulcer prevention dressings
An innovative dressing that helps reduce friction and protect vulnerable areas of skin could be used to prevent pressure ulcers among hospital patients, according to the National Institute for Health and Care Excellence. (Source: Nursing Times)
Source: Nursing Times - October 25, 2017 Category: Nursing Source Type: news

Fifth of female pensioners physically disabled by 2047
Numbers of disabled older people set to rise significantly Related items fromOnMedica GPs should routinely ask elderly about falls, says NICE Active elderly live independently and avoid social care Confusion in the elderly Fragmented system is failing older people, say experts Poor discharge of elderly people costs NHS £820m (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 24, 2017 Category: UK Health Source Type: news

NICE approves gene therapy for rare ‘bubble baby syndrome’
Strimvelis, a treatment for an ultra-rare inherited immune deficiency condition that has been dubbed ‘bubble baby syndrome’, has been approved by NICE in draft guidance. (Source: NHS Networks)
Source: NHS Networks - October 24, 2017 Category: UK Health Source Type: news

The Guardian view on gene therapy: money well spent | Editorial
A rare and fatal disease will be now treated on the NHS. But the real problems come from common and unglamorous complaintsThe NHS is tofund a very expensive treatment for a very rare but terrible childhood disorder that leaves babies condemned to life in a sterile bubble. This is a triumph for medical science but it should also provoke some deep and careful thought. The treatment in question, strimvelis, qualifies as the second most expensive drug ever put on the market (the only one more expensive waswithdrawn due to lack of demand). A single dose costs nearly £500,000 plus VAT, and can only be administere...
Source: Guardian Unlimited Science - October 23, 2017 Category: Science Authors: Editorial Tags: Medical research Stem cells Genetics Biology Science NHS Health Society Children UK news Source Type: news

Who bears the cost of NICE public health recommendations? - Hinde S, Wiyani A, Griffin S, Walker S.
BACKGROUND: In the UK, NICE issues guidance on public health initiatives. Failure to report which sectors of the economy are affected by their implementation precludes the appropriate accounting for the full opportunity costs, and has the potential to resu... (Source: SafetyLit)
Source: SafetyLit - October 23, 2017 Category: International Medicine & Public Health Tags: Commentary Source Type: news

Gene therapy for 'bubble baby' syndrome approved on NHS
GlaxoSmithKline ’s Strimvelis is the first such treatment to be funded in the UKThe NHS will fund gene therapy for the first time after the UK ’s healthcare cost watchdog approved treatment for the so-called “bubble baby” syndrome, despite a price tag of more than £500,000.The treatment is used against adenosine deaminase deficiency, or ADA-SCID, which disables the immune system and means that children with the illness have to be kept in isolation to avoid infection – hence the “bubble baby” name.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 23, 2017 Category: Science Authors: Reuters Tags: NHS The National Institute for Health and Care Excellence (Nice) Genetics Biology Science GlaxoSmithKline Immunology Medical research UK news Pharmaceuticals industry Society Source Type: news

New support for GPs to fight antimicrobial resistance
13% fall in GP prescribing of antibiotics in past three years Related items fromOnMedica Antibiotics not recommended for acute otitis, says NICE Dipstick test children ’s urine before prescribing antibiotics Tackling antimicrobial resistance Doctors told to halve inappropriate antibiotic prescriptions by 2020 GPs need support to convince public to stop expecting antibiotics (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 23, 2017 Category: UK Health Source Type: news

Britain backs GSK's gene therapy for 'bubble boy' syndrome
(Reuters) - GlaxoSmithKline's gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price tag of almost 600,000 euros ($700,000). (Source: Reuters: Health)
Source: Reuters: Health - October 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

NHS ‘on track’ to transform cancer services
Report outlines ‘significant advances’ Related items fromOnMedica Only half of new cancer drugs extend or improve life Cancer rates climb higher for women than men CCGs struggling to meet cancer targets NICE calls on GPs to diagnose cancer sooner Cracks in cancer commissioning due to NHS reforms (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 19, 2017 Category: UK Health Source Type: news

NICE Guideline on Thyroid Disease
NICE (the National Institute for Health and Care Excellence) has been asked by the Department of Health in England to develop a clinical guideline on thyroid disease for England. This guideline will be used to develop the NICE quality standard for the diagnosis and management of thyroid conditions and the recommendations will be included in the NICE Pathway for thyroid disease. (Source: The British Thyroid Foundation)
Source: The British Thyroid Foundation - October 18, 2017 Category: Endocrinology Tags: Featured News Source Type: news

Nice ice, maybe: Study finds water-repelling surfaces ease ice removal
(University of Nebraska-Lincoln) A new study has discovered that ice grows differently on water-absorbent vs. water-repellent surfaces. The research suggests that applying water-repellent coatings to windshields before winter storms -- or engineering surfaces that inherently repel water -- could enable a strong breeze to handle the burden of ice removal. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 18, 2017 Category: Biology Source Type: news

Yeast spotlights genetic variation's link to drug resistance
(Wellcome Trust Sanger Institute) Researchers have shown that genetic diversity plays a key role in enabling drug resistance to evolve. Scientists at the Wellcome Trust Sanger Institute and the Institute for Research on Cancer and Ageing of Nice in France, show that high genetic diversity can prime new mutations that cause drug resistance. The study published today in Cell Reports has implications for our understanding of the evolution of resistance to antimicrobial and anticancer drugs. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 17, 2017 Category: Biology Source Type: news